Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

Recruiting now

Conditions studied: Atopic Dermatitis

In brief

This study will collect skin measurements from people with atopic dermatitis (AD) using the investigational Nevisense Go device. Participants aged 12 to 89 years with a history of AD flares will use the device at home for about 90 days. Participants will complete device measurements, electronic diary entries, and up to five in-person study visits. The study is based on the idea that changes in skin barrier function may occur before an AD flare becomes visible or symptoms begin. Information collected during the study, including device measurements, diary entries, and investigator assessments, will be used to evaluate whether these changes may help estimate the likelihood of an AD flare before visible signs or symptoms occur.

Key facts

Study ID
NCT07645820
Run by
Castle Biosciences Incorporated
People needed
450
Starts
2026-05-29
Expected to finish
2027-12-31
Last updated by the study team
2026-06-12

Who can join

Age: 12 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.